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Abstract
Although endosomal compartments have been suggested to play a role in unconventional protein secretion, there is scarce
experimental evidence for such involvement. Here we report that recycling endosomes are essential for externalization of
cytoplasmic secretory protein tissue transglutaminase (tTG). The de novo synthesized cytoplasmic tTG does not follow the
classical ER/Golgi-dependent secretion pathway, but is targeted to perinuclear recycling endosomes, and is delivered inside
these vesicles prior to externalization. On its route to the cell surface tTG interacts with internalized b1 integrins inside the
recycling endosomes and is secreted as a complex with recycled b1 integrins. Inactivation of recycling endosomes, blocking
endosome fusion with the plasma membrane, or downregulation of Rab11 GTPase that controls outbound trafficking of
perinuclear recycling endosomes, all abrogate tTG secretion. The initial recruitment of cytoplasmic tTG to recycling
endosomes and subsequent externalization depend on its binding to phosphoinositides on endosomal membranes. These
findings begin to unravel the unconventional mechanism of tTG secretion which utilizes the long loop of endosomal
recycling pathway and indicate involvement of endosomal trafficking in non-classical protein secretion.
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Introduction
A great majority of proteins localized on the cell surface and in
the ECM are transported outside through the classical ER-Golgi
pathway for which the key mechanisms of molecular recognition
and trafficking have been established [1,2]. Yet, there are several
proteins that are found in the extracellular space, but do not have
leader sequence or hydrophobic domains, do not localize to the
ER/Golgi, and lack posttranslational modifications generated in
these compartments [3-8]. Among them, some have primary
function(s) outside the cell, while others function both intra- and
extracellularly [6,7].
Several mechanisms were proposed to function in non-classical
protein secretion. The first, exemplified by externalization of
fibroblast growth factor 2 (FGF2), is characterized by phospho-
lipid-mediated targeting and direct translocation of this protein
across the plasma membrane [9]. The second is based on
sequestration of cytoplasmic proteins such as interleukin-1b (IL-
1b) by secretory lysosomes and their subsequent inflammation-
mediated release into the extracellular space [10,11]. Two other
pathways involve microvesicle-dependent secretion and include
either shedding of vesicles at the plasma membrane or formation
of endosomal intraluminal vesicles/multivesicular bodies that
release internal vesicles outside the cell upon their fusion with
the plasma membrane [12,13]. Also, a recently described non-
classical pathway was reported to depend on autophagosomes
[14,15]. Surprisingly, caspase 1 and GRASP were found to control
several unconventional secretion routes, indicating some shared
steps in the diverse pathways of non-classical secretion [16,17].
Despite this progress, general mechanisms and specific molecular
requirements for trafficking pathways of unconventional secretion
remain to be elucidated.
tTG is a ubiquitous member of the transglutaminase family of
Ca
2+-dependent cross-linking enzymes which also possesses
GTPase, disulfide isomerase and protein kinase activities [18,19].
While the majority of tTG pool is present in the cytoplasm, and
some amounts are found in the mitochondria and nucleus, no tTG
is detected in the ER or Golgi [18]. Depending on cell type, a
significant tTG fraction (1–20%) is localized on the plasma
membrane and in the ECM [19]. tTG has both enzymatic and
non-enzymaticfunctionsat theselocationswhereitcross-links ECM
proteins and modulates the interactions of cells with the ECM and
growth factors by non-covalent regulation of integrins [20–22],
syndecan-4 [23–25], and growth factor receptors [26]. Mounting
data suggest that tTG has common or related functions inside and
outside the cells, such as regulation of cell survival [7–19].
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e19414tTG is constitutively externalized from undamaged cells and
fibroblasts, osteoblasts, endothelial, smooth muscle cells, and
monocytes/macrophages, all contain this protein on their surface
and in the ECM [18]. There is no secretory signal or
hydrophobic/transmembrane domains in tTG [27–28] and
nothing is known regarding the factors that control its secretion.
While many agents regulate cellular tTG levels, biosynthesis, and
degradation, they all concurrently modulate its levels outside the
cell [18,19], suggesting a default pathway for trafficking this
protein to the cell surface. A significant part of the tTG pool is
present in the so-called ‘‘particulate fraction’’ indicating its
association with membranes [18]. The causes of such association
are unclear. It may depend on stable interactions of tTG with
adrenergic receptors [29] or integrins [20]. Otherwise, a direct or
indirect binding to lipids may target this protein to cell
membranes. Two early studies reported in vitro association of
tTG with phospholipids [30,31], however no molecular basis or in
vivo evidence of such interaction was presented. Although
fibronectin and heparan sulphate proteoglycans, two extracellular
binding partners of tTG, and its own transamidating activity, were
all proposed to affect its secretion [25,32,33], they likely impact the
retention of tTG on the surface rather than its outbound
trafficking inside the cell.
In this study, we focus on the intracellular trafficking of tTG on
its route to the cell surface. We demonstrate that the ER/Golgi-
independent trafficking pathway of tTG externalization involves
phosphoinositide-dependent recruitment of cytoplasmic protein to
the perinuclear recycling compartment (PNRC), its delivery inside
these vesicles, their outbound trafficking, and their fusion with the
plasma membrane which releases tTG onto the cell surface. These
results reveal an unexpected role of recycling endosomes in the
unconventional secretion of cytoplasmic tTG.
Results
Kinetics of tTG Externalization and Deposition in the ECM
To study the kinetics of tTG secretion, we employed NIH3T3-
tTG transfectants in which expression of exogenous tTG is silent
unless is induced by mifepristone (Fig. 1A, [26,34]). After induction
of tTG synthesis, its content wasevaluated in the whole cell extracts,
on the cell surface after isolation of biotinylated (surface) tTG, in the
ECM, and in the growth medium. tTG was detected on the cell
surface ,4 h after onset of biosynthesis and its amounts continued
to increase thereafter. In contrast, tTG deposited in the ECM
became detectable ,8 h, and in the medium - ,24 h after
induction. A similar kinetics of tTG externalization and deposition
in the ECM was observed in HUVECs that express endogenous
protein (Fig. 1B). In HUVECs, the de novo synthesized tTG was
found on the surface ,2 h, and in the ECM - ,8 h after onset of its
synthesis, but was not yet detected in the medium. Hence, tTG is
not secreted as soluble protein and then binds back to the cell
surface and the ECM as proposed earlier [32], but appears first on
the outside leaflet of the plasma membrane and only later is
translocated to the ECM. Blocking dynamin-dependent endocytosis
of tTG from the surface [34] excluded a possibility that
internalization hinders the ability of its detection at early time
points of biosynthesis and revealed a dynamic equilibrium between
the secretion of tTG and its removal from the cell surface (Fig. S1).
tTG Secretion Follows the ER/Golgi-Independent
Pathway which Requires Intracellular Membrane Fusion
and Is Stimulated by Ca
2+
To establish whether trafficking of this protein to the surface of
NIH3T3-tTG fibroblasts follows the classical ER/Golgi route, we
employed pharmacologic inhibitors that affect the state of various
cell organelles and cytoskeleton (Fig. 2A). Most of these inhibitors,
including brefeldin and tunicamycin which block the ER/Golgi-
dependent secretion, failed to interfere with the transport of tTG
to the surface. Notably, sodium chlorate, a biosynthetic inhibitor
of heparan sulfate proteoglycans, which blocks the non-classical
secretion of FGF2 [35], and glyburide, an inhibitor of non-classical
IL-1b secretion [10], did not affect tTG externalization. Further,
neither heat shock nor Cu
2+ chelator tetrathiomolybdate that
regulate ER/Golgi-independent secretion of FGF1 [36], altered
the externalization of tTG (Fig. S2). The only exception was N-
ethylmaleimide (NEM), a specific inhibitor of NSF ATPase that is
required for most intracellular membrane fusion events [37],
which reduced the rate of tTG externalization. Also, transient
expression of dominant negative E329Q-NSF mutant [38] in
NIH3T3-tTG cells inhibited tTG secretion (Fig. 2B). The
requirement for NSF-mediated membrane fusion and kinetics of
tTG externalization (Fig. 1) indicate that the protein maintains its
association with membranes during trafficking to the cell surface.
Similarly, in HUVECs, neither brefeldin nor tunicamycin, which
interfered with secretion of b1 integrin via the classical ER/Golgi
Figure 1. Kinetics of tTG Secretion and Deposition into the
ECM. (A) Externalization of exogenous tTG in NIH3T3-tTG fibroblasts.
The cells were induced to synthesize tTG with mifepristone. tTG on the
cell surface was detected by labeling cells with sulpho-NHS-LC-biotin,
isolation of cell surface proteins on Neutravidin-Agarose, and immuno-
blotting. tTG was also immunoprecipitated from the ECM and growth
medium and analyzed by immunoblotting. Total tTG and b-actin levels
in NIH3T3-tTG fibroblasts were determined by direct immunoblotting.
The relative tTG amounts in each cell fraction were quantified and
compared to those at 24 h of induction. (B) Externalization of
endogenous tTG in HUVECs. Cells were labeled with
35S-Translabel
and then chased for indicated time with medium containing no
radioactivity. The de novo synthesized tTG in cell fractions was analyzed
by its immunoprecipitation from whole cell extracts, cell surface protein
fraction, the ECM and growth medium, followed by SDS-PAGE and
fluorography. The relative tTG amounts in cell fractions were quantified
by scintillation counting and compared to those at 8 h of chase. The
lack of b-actin in culture medium was tested by blotting (A) or by
immunoprecipitation, SDS-PAGE and fluorography (B), and showed the
absence of cell lysis. Shown in (A,B) are representative of three
independent experiments. Bars in (A,B) depict means 6 SEM. See also
Figure S1.
doi:10.1371/journal.pone.0019414.g001
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surface binding partner b1 integrin are externalized via indepen-
dent secretory routes. The stimulatory effect of Ca
2+ on tTG
secretion observed in HUVECs was confirmed with WI-38
fibroblasts that also synthesize endogenous protein (Fig. 2D).
Whereas BAPTA decreased the rate of tTG externalization, Ca
2+
ionophore promoted the secretion of tTG. Thus, delivery of
intracellular tTG to the cell surface does not require the ER/Golgi
function and occurs via a non-classical secretion route which
involves intracellular membrane fusion and is promoted by Ca
2+.
Cytoplasmic tTG Is Recruited to Perinuclear Recycling
Endosomes and Delivered Inside these Vesicles Prior to
Externalization
We used immunostaining to examine a potential association of
tTG with intracellular membrane compartments (Fig. 3A). In
agreement with previous report [20], general staining for tTG
allowed detection of this protein in focal adhesions and cytoplasm
of WI-38 fibroblasts. In contrast, methanol fixation revealed
accumulation of tTG around the nucleus. Pre-extraction of live
cells with digitonin before fixation removed most cytoplasmic tTG
and allowed to observe distinct tTG localization in perinuclear
vesicles. Yet, we reported endolysosomal localization of internal-
ized tTG [34]. Thus, to define intracellular localization of tTG
prior to externalization, we used pre-extraction of majority of
cytoplasmic tTG in NIH3T3-tTG fibroblasts shortly after onset of
its synthesis and before the protein reached the surface (Fig. 3B).
Whereas no tTG was detected before induction, the earliest
staining was observed ,1.5 h, and extensive localization at
perinuclear vesicles - ,3 h after initiation of tTG synthesis.
Likewise, the localization of tTG in focal adhesions (Fig. S3A) and
the perinuclear vesicles (Fig. S3B) was observed in NIH3T3-tTG-
His/myc fibroblasts that were induced to express His/myc-tagged
tTG [39], by immunostaining with antibody against the 6xHis tag.
Labeling of NIH3T3-tTG fibroblasts with styryl dye FM4-64FX
3 h after induction of tTG synthesis, followed by pre-extraction of
Figure 2. Externalization of tTG Does Not Involve the Classical ER/Golgi Secretion Pathway, but Requires Membrane Fusion and is
Stimulated by Ca
2+. (A) Non-classical secretion of tTG in NIH3T3-tTG fibroblasts. Cells were treated with inhibitors and then induced for 4 h with
mifepristone before cell surface biotinylation and isolation of surface proteins. Cell surface and total tTG levels were defined by immunoblotting. The
relative surface tTG levels were quantified and compared to that in untreated cells. (B) NSF-mediated membrane fusion is required for tTG secretion in
NIH3T3-tTG fibroblasts. Cells were transiently transfected with increasing amounts of plasmid encoding the myc-tagged E329Q dominant negative
NSF mutant. After 48 h, the transfectants were induced to synthesize tTG for 4 h. The levels of E329Q-NSF-myc were defined by immunoblotting with
anti-myc antibody. The total and surface levels of tTG were determined as in (A). (C) Non-classical secretion of tTG in HUVECs. Cells were treated with
inhibitors and then labeled for 6 h with
35S-Translabel before cell surface biotinylation and isolation of surface proteins. (D) Intracellular Ca
2+ levels
regulate tTG externalization in WI-38 fibroblasts. Cells were treated for 1 h with BAPTA or Ca
2+ ionophore and then labeled for 6 h with
35S-Translabel
before cell surface biotinylation and isolation of surface proteins. Cell surface levels of de novo synthesized tTG and b1 integrin and total levels of tTG
in (C,D) were defined by immunoprecipitation, SDS-PAGE and fluorography. The relative surface levels of tTG and b1 integrin were quantified by
scintillation counting and compared to those in untreated cells. Shown in (A–D) are representative of three independent experiments. Bars in (A,C,D)
depict means 6 SEM, *p,0.05, **p,0.005. See also Figure S2.
doi:10.1371/journal.pone.0019414.g002
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Externalization. (A) WI-38 fibroblasts were fixed and permeabilized with formaldehyde and Triton X-100, fixed/permeabilized with ice-cold
methanol, or permeabilized at 4uC with digitonin in QP buffer before fixation (see Materials and Methods). Note the localization of tTG in focal
adhesions (arrowheads) and its accumulation in perinuclear vesicles (insert). (B) NIH3T3-tTG fibroblasts induced to synthesize tTG for 0–3 h, were
extracted with digitonin before fixation and then stained for tTG. Immunofluorescence in (A,B) was analyzed by conventional microscopy. Scale bars -
10 mm. (C) NIH3T3-tTG fibroblasts were induced to synthesize tTG for 3 h, then labeled with lipophylic dye FM4-64FX, washed, extracted with
digitonin, fixed, and stained for tTG. The digitonin-extracted cells were also double-stained for tTG and the marker of recycling endosomes, Rab11.
Note a significant co-localization of tTG with perinuclear membranes and Rab11 (inserts). Immunofluorescence was analyzed by laser confocal
microscopy. Scale bar - 10 mm. (D) Immunoelectron microscopic localization of tTG in NIH3T3-tTG fibroblasts 3 h after induction of synthesis. Double
labeling of thin sections was performed for tTG (6 nm gold, arrowheads) and Rab11 (10 nm gold, arrows, left panel) or lysosomal marker Lamp3
(10 nm gold, arrows, right panel). Asterisks mark selected vesicles shown as inserts at higher magnifications. NM - nuclear membrane; PM - plasma
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revealed a significant overlap between tTG localization and
perinuclear membrane compartments (Fig. 3C). This indicated
that de novo synthesized tTG is targeted to the PNRC prior to
externalization. Double staining of these cells for tTG and the
recycling endosomal marker Rab11, the late endosomal marker
Rab7, and the lysosomal marker Lamp1, allowed to observe a
substantial colocalization of tTG with Rab11 on a subset of
perinuclear vesicles (Fig. 3C), whereas little codistribution of tTG
with Rab7 or Lamp1 was found (Fig. S3C). Finally, using double
immunogold labeling of thin sections of the NIH3T3-tTG
fibroblasts early after induction of tTG synthesis, and electron
microscopy, we found a prominent colocalization of tTG with
Rab11 in the recycling endosomes (Fig. 3D) and presence of tTG
on intralumenal vesicles of multivesicular endosomes (Fig. S3D),
but observed little co-distribution of tTG with the lysosomal
marker Lamp3. The localization of tTG on the intralumenal
endosomal vesicles suggested that ESCRT-dependent inward
budding of the limiting endosomal membrane might be involved
in tTG secretion. However, shRNA-mediated depletion of
ESCRT proteins Tsg101 and Vps24 did not affect tTG
externalization, indicating that ESCRT function is dispensable
for intravesicular delivery of cytoplasmic tTG (Fig. S4).
To biochemically ascertain the content of tTG in various cell
membranes, we isolated a crude fraction of light and medium
membranes [10,11] 3 h after tTG induction in NIH3T3-tTG
fibroblasts and used it for immunoaffinity isolation of vesicular
organelles [40–42]. Biochemical analysis of immunoisolated
membranes showed an enrichment of tTG in Rab11-containing
recycling endosomes and its low content in other membrane types
early after induction of its biosynthesis (Fig. 3E). The sidedness of
newly synthesized tTG in relation to the Rab11-containing vesicles
was examined by proteinase protection assays (Fig. 3F, [10]).
Without detergent, proteinase K eliminated ,70% of tTG in
recycling endosomes, whereas ,30% of this tTG pool was
protected from degradation. In control experiments, all Rab11A
outside the vesicles was digested with proteinase K even in the
absence of detergent, while both tTG and Rab11A were
completely degraded upon addition of detergent. Further,
proteinase K eliminated all the tTG and Rab11A in recycling
endosomes after their sonication, whereas high salt treatment left a
significant fraction of tTG undegraded, proving that this latter
part of endosomal tTG pool is present inside the vesicles.
Therefore, cytoplasmic tTG binds to and is delivered inside the
Rab11-containing PNRC shortly after onset of its biosynthesis but
prior to externalization.
We also tested a delivery of purified recombinant tTG inside the
recycling endosomes isolated from NIH3T3 fibroblasts lacking
tTG (Fig. 3G). After incubation of tTG with recycling endosomes
at 4uC, the protein bound to the vesicles. Their treatment with
proteinase K without detergent revealed a complete degradation
of vesicle-bound tTG, showing a lack of its delivery inside the
vesicles in the absence of additional factors. While separate
addition of Mg
2+/ATP or cytosol from NIH3T3 cells lacking tTG
did not produce any protease-protected tTG, their combination
led to emergence of some tTG resistant to proteolysis. Hence, the
delivery of endosome-bound tTG inside these vesicles requires
ATP and some cytosolic factor(s). Finally, the proteinase
protection experiments were repeated with recycling endosomes
isolated from NIH3T3-tTG fibroblasts that expressed either wild
type NSF or its E329Q dominant negative mutant (Fig. 3H).
Inactive NSF mutant increased the overall tTG content on the
recycling endosomes but abolished tTG delivery inside these
vesicles. Thus, NSF and vesicular fusion are required for the
delivery of endomembrane-bound tTG inside the recycling
endosomes.
Endosome Inactivation, Blocking Endosome Fusion with
the Plasma Membrane, and Interference with the Long
Loop of Endosomal Recycling, all Abrogate tTG Secretion
In order to assess the overall contribution of recycling
endosomes to the process of tTG secretion, we utilized ablation
of this compartment based on the formation of insoluble
precipitate of horseradish peroxidase-transferrin (HRP-Tf) conju-
gates by cross-linking with diaminobenzidine (DAB) and hydrogen
peroxide (Fig. 4A, [43]). Functional inactivation of recycling
endosomes prior to tTG induction in NIH3T3-tTG fibroblasts
reduced its surface level without altering the overall content of the
protein, and also decreased the surface level of b1 integrin which is
recycled through the PNRC [44,45]. In contrast, inactivation of
lysosomes by accumulation of free HRP and its cross-linking with
DAB and hydrogen peroxide had no effect on tTG secretion or b1
integrin recycling. Therefore, recycling endosomes represent the
main compartment that accumulates tTG on its route to the cell
surface.
Then, we focused on the vesicular and target soluble NSF
attachment protein receptors (v-SNAREs and t-SNAREs) that
drive fusion of recycling endosomes with the plasma membrane.
VAMP3 and SNAP23 SNAREs are involved in this process in
non-neuronal cells and are required for recycling of b1 integrins
from the PNRC to the surface [46]. Expression of Tetanus
neurotoxin (TeTx-LC) which inactivates VAMP3 [47], or
dominant negative dc9-SNAP23 mutant [46] in NIH3T3-tTG
fibroblasts, was followed by induction of tTG synthesis and
analysis of its surface levels (Fig. 4B and 4C). VAMP3 cleavage or
interference with SNAP23 function both reduced the rate of tTG
secretion. Thus, these SNAREs are involved in the fusion of tTG-
bearing endosomes with the plasma membrane.
We also used shRNA-based approach to probe the role of
regulatory proteins that control endocytic trafficking pathways, in
membrane. Note a co-distribution of tTG and Rab11 on the vesicles and a general lack of thereof for tTG and Lamp3. (E) Intracellular tTG is associated
with recycling endosomes. NIH3T3-tTG fibroblasts were induced to synthesize tTG for 3 h. Early/late endosomes (EE/LE), recycling endosomes (RE),
lysosomes (LY), ER, Golgi (GL), and plasma membrane (PM) vesicles were isolated from crude membrane fraction using magnetic beads coated with
antibodies to organelle markers. tTG levels were determined by SDS-PAGE and immunoblotting. Note the enrichment of tTG in recycling endosomes
and its low levels - in early/late endosomes and plasma membrane. (F) tTG is present inside the recycling endosomes prior to externalization. The
recycling endosomes isolated from NIH3T3-tTG fibroblasts 3 h after induction of tTG synthesis were treated at 4uC with proteinase K, with or without
Triton X-100, sonication or high salt. (G) tTG delivery inside the endosomes requires ATP and cytosolic factor(s). Recycling endosomes
immunoisolated from NIH3T3 fibroblasts lacking tTG were incubated for 1 h at 4uC with exogenous tTG, washed, warmed to 37uC for 1 h in the
presence or absence of Mg
2+/ATP and cytosol from the cells lacking tTG, and then treated with proteinase K with or without Triton X-100. (H)
Membrane fusion is required for tTG delivery inside the recycling endosomes. NIH3T3-tTG fibroblasts were transfected with myc-tagged wild type
NSF or its dominant negative E329Q mutant and induced to synthesize tTG for 3 h. Recycling endosomes were isolated from the transfectants and
treated with proteinase K with or without Triton X-100. The contents of tTG (E–H) and Rab11A (F) in the vesicles were defined by immunoblotting.
Shown in (E–H) are representative of three independent experiments. See also Figure S3 and Fig. S4.
doi:10.1371/journal.pone.0019414.g003
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Rab4A/B, Arf6, Rab5A and Rab22A in NIH3T3-tTG fibroblasts
did not affect tTG secretion, depletion of Rab11A, and even more
so, of Rab11B, inhibited tTG externalization. Transient expression
of the S25N-Rab11A or S25N-Rab11B dominant negative mutants
[48] in these cells showed a reduction in surface tTG levels in the
transfectants and confirmed the involvement of Rab11A and
Rab11B in the process of tTG secretion (Fig. 4E). Hence, Rab11A/
B GTPases that control endosomal trafficking from the PNRC to
the cell surface [49], are involved in tTG externalization.
Figure 4. Endosome Ablation, Interference with Endosome to Plasma Membrane Fusion, and locking Rab11-Mediated Endosomal
Recycling, all Inhibit tTG Externalization. (A) Functional inactivation of recycling endosomes inhibits tTG secretion. NIH3T3-tTG fibroblasts were
incubated with HRP-transferrin or HRP, followed by DAB/H2O2 treatment, to ablate the recycling endosomes or lysosomes, respectively [43]. (B)
Proteolysis of VAMP by Tetanus toxin inhibits tTG secretion. The light (catalytic) chain of Tetanus toxin (TeTx-LC) was expressed in NIH3T3-tTG
fibroblasts. The TeTx-LC and VAMP3 levels were tested by immunoblotting. (C) Interference with SNAP23 function reduces tTG secretion. Wild type
SNAP23 and its dominant negative dc9-SNAP23 mutant were expressed in NIH3T3-tTG fibroblasts as myc-tagged proteins and their levels were
defined by immunoblotting. (D) Downregulation of Rab11A/Rab11B inhibits tTG secretion. shRNAs for Rab4A/B, Rab11A/B, Arf6, Rab5A and Rab22A
and scrambled control were expressed in NIH3T3-tTG fibroblasts. tTG synthesis in (A–D) was induced for 4 h prior to cell surface biotinylation and
isolation of surface proteins. Cell surface and total levels of tTG, b1 integrin and tubulin were defined by immunoblotting. The relative surface levels
of tTG (A–D) and b1 integrin (A) were compared to those in DAB/H2O2-treated cells (A) or control transfectants (B–D). Shown in (A–D) are
representative of three independent experiments. Bars show means 6 SEM, *p,0.05, **p,0.005. (E) Interference with GTPase activity of Rab11
decreases tTG externalization. NIH3T3-tTG fibroblasts were transfected with wild type Rab11A, Rab11B, or their S25N dominant negative mutants
fused to GFP. 48 h later the transfectants were induced to synthesize tTG for 4 h and live cells were stained at 4uC for surface tTG. Two-color flow
cytometry of surface tTG (phycoerythrin) and transfected Rab11 proteins (GFP) levels is shown for gated live transfectants. Note a reduction in surface
tTG levels in the transfectants that express high levels of Rab11A and Rab11B dominant negative mutants (right quadrants). Shown is representative
of four independent experiments.
doi:10.1371/journal.pone.0019414.g004
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on Route to Secretion and is Delivered to the Cell Surface
as a Complex with Recycled b1 Integrins
Since the de novo synthesized tTG forms complexes with its cell
surface binding partners b1 integrins prior to externalization [20],
and recycling of b1 integrins from the PRNC to the cell surface is
Rab11-dependent [48,49], we sought to determine whether the
two proteins interact inside this compartment prior to tTG
externalization (Fig. 5). Using co-immunoprecipitation analysis
after induction of tTG synthesis for 3 h in the NIH3T3-tTG
fibroblasts, we confirmed our earlier observations with human
erythroleukemia (HEL) cells [20] that this protein is associated
Figure 5. tTG Binds to b1 Integrins Undergoing the Recycling Process Within the Perinuclear Recycling Endosomes. NIH3T3-tTG
fibroblasts were induced to synthesize tTG with mifepristone for 3 h (A–D) or 5 h (E,F). (A) tTG forms complexes with b1 integrins prior to secretion.
The total levels of tTG, b1 integrins and tubulin were determined by immunoblotting. Cell surface levels of tTG and b1 integrins were defined by
labeling cells with sulpho-NHS-LC-biotin, isolation of cell surface proteins on Neutravidin-Agarose, and immunoblotting. b1 integrins were
immunoprecipitated from total cell lysates and the resulting immune complexes were probed for b1 integrin and tTG. (B) Recycling endosomes
contain the b1 integrin-tTG complexes. Recycling endosomes (RE) were isolated from crude membrane fraction using magnetic beads coated with
antibody to Rab11. The levels of tTG and Rab11A in the RE were defined by immunoblotting. b1 integrins were immuno-precipitated from the RE
lysates and the immune complexes were probed for b1 integrin and tTG. (C) tTG colocalizes with internalized b1 integrins in perinuclear recycling
endosomes. Antibody uptake experiment was performed with surface-bound 9EG7-Fab against the b1 integrin subunit. Digitonin-extracted cells
were double-stained for tTG and internalized b1 integrins. Arrows mark colocalization of internalized b1 integrin-9EG7-Fab complexes with tTG on
the PNRC vesicles. Immunofluorescence was analyzed by conventional microscopy. Scale bar - 10 mm. (D) The de novo synthesized tTG binds to
internalized b1 integrins. tTG synthesis was induced 3 h before the end of metabolic labeling with
35S-Translabel. Antibody uptake experiment was
performed with surface-bound 9EG7-Fab against the b1 integrin subunit. Internalized
35S-labeled b1 integrins and associated proteins were analyzed
by immunoprecipitation, SDS-PAGE and fluorography. The association of tTG with internalized b1 integrins was confirmed by its reprecipitation from
the b1 integrin immune complexes. (E) tTG is associated with the fraction of recycled proteins. Surface labeling and generation of the fractions of
internalized proteins, (two left lanes), recycled proteins (two middle lanes), and internalized proteins retained intracellularly after the recycling (two
right lanes), were performed as in [44], (see also Materials and Methods). After cell lysis, biotinylated and unlabeled associated proteins in these
fractions were isolated on neutravidin-Agarose and b1 integrins and tTG were detected by SDS-PAGE and immunoblotting. (F) Externalized tTG is
associated with the recycled a5b1 integrin. The fractions of internalized proteins, recycled proteins, and internalized proteins retained intracellularly
after the recycling, were obtained as in (E). Following surface labeling and incubations, 4G3-Fab against tTG was bound to the cell surfaces at 4uC.
Surface tTG and associated proteins were immunoprecipitated from cell lysates and the immune complexes were probed by immunoblotting for a5
and b1 integrins and for biotinylated (cell surface-derived) proteins by blotting with neutravidin-peroxidase. Shown in (A,B,D-F) are representative of
three independent experiments.
doi:10.1371/journal.pone.0019414.g005
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association occurs inside the PNRC, as de novo synthesized tTG
was detected in the b1 integrin immune complexes isolated from
the Rab11-positive recycling endosomes (Fig. 5B) and was
partilally co-localized in the perinluclear vesicles with the b1
integrins internalized from the surface of NIH3T3-tTG fibroblasts
(Fig. 5C). Finally, we confirmed the binding of de novo synthesized
tTG to the internalized b1 integrins in these cells by co-
immunoprecipitation analysis after metabolic labeling (Fig. 5D).
Next, we set to examine whether tTG is exported in these cells
as a complex with intracellular b1 integrins recycled back to the
cell surface (Fig. 5E,F). Cell surface proteins were labeled with
reducible sulfo-NHS-SS-biotin 3 h after induction of tTG
synthesis, allowed to undergo endocytosis for 15 min, and the
remaining surface biotin label was stripped with the reducing
agent MESNA (Fig. 5E, [44]). The fractions of internalized
proteins, the ones recycled back to the surface for additional
45 min after the MESNA treatment, and the ones retained
intracellularly after the recycling, were all isolated on neutravidin-
Agarose beads. In agreement with previous report [44], the
majority of internalized proteins, including .80% of b1 integrins,
recycled back to the surface of the NIH3T3-tTG fibroblasts under
these conditions (Fig. 5E). Notably, immunoblotting revealed an
association of de novo synthesized tTG with both the internalized
and recycled proteins in these cells (Fig. 5E). To identify the
binding partners for secreted tTG in these cellular fractions, cell
surface-bound Fab fragment of mAb 4G3 [21] was used to pull-
down externalized tTG together with associated proteins (Fig. 5F).
Probing the resulting tTG immune complexes for a5 and b1
integrins by immunoblotting and the cell surface-derived proteins
by blotting with neutravidin-peroxidase revealed an association of
externalized tTG with the recycled a5b1 integrin. Therefore, de
novo synthesized tTG interacts with internalized b1 integrins in the
PNRC on its route to secretion and is delivered to the cell surface
as a complex with recycled b1 integrins.
Interaction with Phosphoinositides Is Required for
Targeting Cytoplasmic tTG to Endosomal Membranes
and Externalization
We hypothesized that phospholipids of endosomal membranes
might be involved in targeting tTG to the PNRC and measured
the binding of tTG to these organelles after their immunoisolation
from NIH3T3 cells lacking this protein (Fig. 6A). The recombi-
nant tTG exhibited a specific, dose-dependent and saturable
binding to the recycling endosomes with the Kd ,20 nM.
Preincubation of tTG with 100 mM purified phosphatidyl-
inositol (3,5)-diphosphate [PI(3,5)P2], phosphatidylinositol (3,4)-
diphosphate [PI(4,5)P2], phosphatidic acid [PA], phosphatidylino-
sitol (3)-phosphate [PI(3)P] or phosphatidylinositol (4)-phosphate
[PI(4)P] diminished its binding to the vesicles with the latter two
phosphoinositides having the strongest inhibitory effect, yet it did
not affect the relative content of Rab11A/Rab11B on these
vesicles (Fig. 6B). Thus, binding to membrane phospholipids is
involved in the association of cytoplasmic tTG with transport
vesicles.
In search for molecular motifs involved in the tTG binding to
phosphoinositides, we identified the sequence …(590)KIRIL-
GEPKQRKK(602)… that fits the consensus K/RX(3–5)K/
RXK/RK/R for phospholipid binding (Fig. 6C, [50,51]) and is
not shared by other members of the transglutaminase family [18].
The residues K598, K600, R601 and K602 form a positively
charged cluster on the surface of the fourth domain (marked in yellow).
In vitro binding assays with recombinant tTG and immobilized
membrane lipids (Fig. S5A) or phosphoinositides (Fig. S5B) showed
its interaction with PA, phosphatidylserine (PS), PI(4)P, PI(3)P,
phosphatidylinositol (5)-phosphate [PI(5)P], PI(3,5)P2, PI(4,5)P2,
phosphatidyl-inositol (3,4)-diphosphate [PI(3,4)P2], and non-phos-
pholipid membrane compounds cardiolipin and sulfatide. In all the
cases except that of sulfatide, the interaction was inhibited by Ca
2+.
Yet, only a weak interaction with phosphatidylinositol (3,4,5)-
triphosphate [PI(3,4,5)P3], and no binding to phosphoinositol (PI),
phosphatidylcholine (PC), phosphatidylethanolamine (PE), choles-
terol, and sphyngomyelin was observed. A quantitative in vitro
analysis of tTG interaction with synthetic phosphoinositide-
containing liposomes revealed that it binds monophosphates
PI(3)P, PI(4)P and PI(5)P with highest affinity, while diphosphates
PI(3,4)P2, PI(3,5)P2, and PI(4,5)P2 exhibit weaker interaction and
triphosphate PI(3,4,5)P3 only negligibly binds to tTG (Fig. 6D). This
order of interactions is reverse to typical for most phospholipid-
binding proteins [50,51] and is due to negatively charged E596
residue adjacent to the positively charged cluster. Importantly,
immunoprecipitation from WI-38 fibroblasts showed a tight tTG
binding to PI(3)P and PI(4)P and inhibition of this interaction by
Ca
2+ (Fig. 6E), whereas the recombinant tTG from E. coli had no
bound phospholipids (Fig. S4C). Thus, the phospholipid-binding
site in this protein allows it to interact with a wide range of
membrane phosphoinositides.
Finally, we examined the role of phospholipid binding in the
interaction of cytoplasmic tTG with transport vesicles and its
trafficking to the cell surface (Fig. 6F). We used neomycin, a drug
that blocks the interaction of proteins with phosphoinositides [9]
and generated the tTG mutant K598A,K600A,R601A,K602A
(m-plbs) with altered phospholipid-binding site, which failed to
bind PI(3)P and PI(4)P upon expression in NIH3T3 fibroblasts
(Fig. S4D). Both neomycin treatment and mutation of the
phospholipid-binding site reduced the association of tTG with
recycling endosomes and inhibited its secretion. We concluded
that the interaction with phosphoinositides is required for
recruitment of cytoplasmic tTG to recycling endosomes and
subsequent externalization.
Discussion
In this study we begin to delineate the unconventional mechanism
of tTG secretion. We find that externalization of tTG to the cell
surface does not require the ER/Golgi function, but follows a non-
classical vesicle-mediated pathway based on its recruitment to the
membranes of PNRC and utilizing the long endosomal recycling
loop for secretion. The initial recruitment of cytoplasmic tTG to the
endosomal membranes depends on phosphoinositide binding, and
membrane-boundtTGisdeliveredinsidetheperinuclearendosomes
prior to externalization. Finally, regulatory Rab11A/Rab11B
GTPases that control outbound trafficking of the tTG-bearing
recycling endosomes, and VAMP3 and SNAP23 SNAREs that
mediate endosome to plasma membrane fusion, are all involved in
tTG secretion. Hence, this work provides a novel example of the use
of endosomal recycling pathway for non-classical externalization of
cytoplasmic secretory protein.
Based on the observations presented here, we propose a
pathway of constitutive tTG secretion which is likely common
for many cell types that express this protein (Fig. 6G). It includes:
{1} phospholipid-dependent binding of cytoplasmic tTG to the
PNRC vesicles; {2} delivery of the membrane-bound tTG inside
these transport vesicles; {3} anterograde movement of these
vesicles; and {4} their fusion with the plasma membrane which
exposes intravesicular tTG to the extracellular space. Several
features of this pathway distinguish it from other reported or
proposed mechanisms of unconventional secretion pathways for
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Externalization. (A) Binding of tTG to recycling endosomes. The amounts of purified
125I-tTG bound at 4uC to recycling endosomes immunoisolated
from NIH3T3 cells lacking tTG were determined in a gamma counter with all measurements performed in triplicates. Shown are means 6 SEM for
three independent experiments. (B) The role of phosphoinositides in the tTG interaction with recycling endosomes. Binding of 50 nM purified tTG to
recycling endosomes was tested in the presence of 100 mM free phosphoinositides. Bound tTG and endosomal Rab11A/Rab11B and transferrin
receptor (TfR) were detected by immuno-blotting. The relative amounts of vesicle-bound tTG were quantified and compared to that in the sample
without phosphoinositides in four independent experiments. Bars depict means 6 SEM, *p,0.05. (C) The putative phospholipid-binding sequence
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requirement for endosomal targeting sets it apart from vesicle-
independent non-classical secretion pathways described for FGF1
and FGF2 [5–7]. The lack of lysosomal targeting of tTG and
insensitivity of its trafficking to inhibitors of lysosomal function
indicates that the tTG secretion route does not involve protein
sequestration by secretory lysosomes as shown for inflammation-
induced IL-1b release by macrophages [10,11]. Although in
macrophages various inflammatory cytokines increase surface tTG
level [21], this occurs via transcriptional upregulation rather than
induction of its trafficking and externalization [18]. Moreover, in
all the reported cases cytoplasmic tTG undergoes a constitutive
secretion in diverse types of cells [18,19]. Thus, unlike most routes
of unconventional secretion, the default tTG secretion pathway is
designed to operate in a wide variety rather than in a selected cell
type, as is the case for FGF2 in fibroblasts [6,9] or IL-1b in
macrophages [10-13]. Likewise, the delivery of tTG onto the cell
surface precedes its extracellular appearance, indicating that the
tTG secretion pathway does not involve shedding of microvesicles
at the extracellular side of the plasma membrane and exosome
release [6,12,13].
At the moment, the mechanism(s) of tTG delivery inside the
PNRC vesicles remain unknown. While we do not rule out a
potential role for transmembrane transporters [6,8,10] in shuttling
the endomembrane-bound tTG inside the PNRC, our biochemical
experiments with isolated endosomes and the dominant negative
NSF mutant, combined with electron microscopy observations,
favor an involvement of membrane fusion events and/or endo-
somal budding in the delivery of endomembrane-bound tTG inside
the transport vesicles. Also, one can not exclude an involve-
ment of Rab11-containing amphisomes and/or autophagosomes
[8,14,15,53] and their fusion with recycling endosomes, in the
process of tTG secretion. Furthermore, the localization of tTG on
intralumenal vesicles of multivesicular endosomes reported in this
study may result from the ESCRT-independent inward budding
and scission of the limiting endosomal membrane during the
formation of multivesicular endosomes [52]. Finally, our data
implicate membrane fusion events in the fusion of the tTG-bearing
recycling trasport vesicles with the plasma membrane at the final
stage of tTG delivery onto the cell surface.
In addition to some unique features of this unconventional
secretion pathway, the constitutive route of tTG externalization
shares several general principles utilized in unconventional
secretion of other cytoplasmic proteins. For cytoplasmic tTG,
targeting cargo protein to endosomal membranes occurs via its
interaction with a subset of phosphoinsitides, like in the case of
FGF2 [9], although spatial specificity of membrane docking sites
(inner leaflet of plasma membrane versus endosomal membrane)
are different. The preferential binding of tTG to PI(3)P fits well the
phospholipid composition of endosomal membranes that are
enriched in this phosphoinositide [49]. Further, the interaction of
cytoplasmic tTG with intracellular transport vesicles may
represent a two-step process with its initial tethering to endosomal
phospholipids and subsequent tight binding to endomembrane
protein(s) acting as tTG receptor(s). A search for such tTG-binding
partner(s) on the endosomal membranes is currently underway.
Finally, Ca
2+ serves as a common regulator of this and other non-
classical secretion pathways by promoting vesicular trafficking
and/or membrane fusion events [54].
The emerging relationship of this unconventional trafficking
pathway to the general recycling routes of integrins has important
functional implications (Fig. 6G). Several features of tTG secretion
including its dependence on Rab11 function and VAMP3- and
SNAP23-mediated endosome to plasma membrane fusion coin-
cide with those governing integrin recycling [44], suggesting that
tTG is exported inside the same vesicles that contain integrins
undergoing the recycling process. We identified b1 and b3
integrins as the principal binding partners for tTG on the cell
surface, and showed a major role of the integrin-tTG complexes in
cell-ECM interactions and outside-in signaling [20,21,55]. More-
over, our previous studies indicated that tTG binds b1 integrin
within 30–60 min after onset of biosynthesis [20], but the lack of
tTG in the ER/Golgi left unresolved the issue of cellular
compartment in which these complexes are formed. The targeting
of cytoplasmic tTG to the PNRC provides a novel explanation for
these earlier findings. Both b1 and b3 integrins undergo
endocytosis with the former utilizing the long, PNRC-mediated,
and the latter - the short recycling routes [44]. While low levels of
avb3 integrin in the NIH3T3-tTG fibroblasts [55,56] precluded
analysis of its intracellular interaction with tTG, we identified the
internalized a5b1 integrin as a key binding partner for tTG inside
the PNRC vesicles and showed that de novo synthesized tTG is
externalized as a complex with this integrin via the long recycling
route. We envision that targeted delivery of intracellular adhesive/
signaling integrin-tTG complexes to lamellipodia should strength-
en adhesion to the ECM at the leading edge of migrating cell and
contribute to directionality of cell migration. This hypothesis will
be tested in our future work.
Materials and Methods
Reagents and Antibodies
Unless stated otherwise, all chemicals were obtained from
Sigma-Aldrich. NEM was obtained from EMD Biosciences.
35S-Translabel was obtained from MP Biomedicals. Sulfo-NHS-
LC-biotin, Sulfo-NHS-SS-biotin, neutravidin-Agarose, neutravidin-
peroxidase, Protein G-Agarose, PVDF membranes, secondary
peroxidase-labeled IgGs, and ECL reagents were from Pierce
Biotechnology. Mifepristone was from Invitrogen (#H11001). 6 nm
goat anti-mouse IgG gold conjugate and 10 nm goat anti-rabbit IgG
and site within the fourth domain of tTG. (D) Comparative analysis of tTG binding to phosphoinositides.
125I-tTG binding to synthetic liposomes
(PolyPIPosomes
TM) containing indicated phiosphoinositides was determined in a gamma counter with all measurements performed in triplicates.
Shown are means 6 SEM for three independent experiments. (E) Association of tTG with phosphoinositides in cells. tTG was immunoprecipitated
from extracts of WI-38 fibroblasts and the immune complexes were probed by immunoblotting for PI(3)P or PI(4)P. (F) The phospholipid-binding site
in tTG is required for membrane targeting and externalization of the protein. K598A,K600A,R601A,K602A mutations (m-plbs) were generated within
the phospholipid-binding site of tTG. NIH3T3 fibroblasts transfected with wild type tTG (wt) or its mutant deficient in phosphoinositide binding (m-
plbs) were left untreated or treated with 10 mM neomycin for 24 h before induction of these proteins for 4 h. The contents of wt and m-plbs tTG in
the recycling endosomes and cytosol were defined by immunoblotting (left panels). Cell surface and total levels of wt and m-plbs tTG were defined by
surface biotinylation, isolation of surface protein fractions, and immunoblotting (right panels). The relative contents of wt and m-plbs tTG in the
recycling endosomes and on the cell surface were quantified and compared to those for untreated cells expressing wt protein. Shown are
representative of three independent experiments. Bars depict means 6 SEM, **p,0.005. See also Figure S5. (G) A proposed mechanism of
unconventional tTG secretion. The de novo synthesized intracellular (cytoplasmic) tTG (hexagons) does not follow the classical, ER/Golgi-dependent
secretion pathway, but is exported via a four-step unconventional secretion process mediated by recycling endosomes (dotted arrows). Solid arrows
mark the major intracellular recycling route through the PNRC utilized by b1 integrins. See further comments in the text.
doi:10.1371/journal.pone.0019414.g006
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DynalH Dynabeads coupled with anti-mouse IgG, anti-rabbit
IgG, or streptavidin for isolation of biotinylated plasma
membrane vesicles, were from Invitrogen. PE-labeled secondary
antibodies were from BD Biosciences. Purified recombinant His-
tagged human tTG was obtained from Zedira. Membrane lipid
strips (#P6002); PIP strips (#P6001), PolyPIPosomes (#YP000;
#YP003; #YP004; #YP005; #YP034; #YP035; #YP045;
#YP039), and purified synthetic phosphoinositides were from
Echelon Biosciences. Membrane styryl dye FM4-64FX and
secondary IgGs conjugated with Alexa Fluor 488 and Alexa
Fluor 594 were from Molecular Probes/Invitrogen. mAbs
CUB7402 and TG100 against tTG were from LabVision/
Neomarkers. mAb 4G3 against human tTG was characterized
earlier [21]. Antibody to 6xHis tag was from Genscript. Rat anti-
mouse/human b1 integrin, clone 9EG7, was from BD Biosci-
ences, #553715. Rabbit antibody to the cytoplasmic domain of
b1 integrin was from Millipore, #AB1952. Antibody #610657
to Rab11A/Rab11B was from BD Biosciences. Antibodies to
b-actin, #sc8432; b-tubulin, #sc9104; c-myc, #sc-40; Rab7,
#sc10767; Rab11A, #sc25690; Rab11B, #sc26591; EEA1,
#sc6414; LAMP1; #sc8098, LAMP3, sc#98658; VAMP3,
sc#18208; calnexin, #sc6465; were all obtained from Santa
Cruz Biotechnology. Polyclonal antibody against GM130 was
described earlier (57). Rabbit polyclonal antibodies to Tsg101,
ab30871, and Vps24, ab76333, were obtained from Abcam.
Antibodies to PI(3)P, #Z-P003, and PI(4)P, #Z-P004, were from
Echelon Biosciences. Dynasore, a cell-permeable small molecule
that inhibits the GTPase activity of dynamin-1, dynamin-2, and
Drp1 (58), was obtained from Tocris Biosciences (#2897).
Cells, Constructs and Transfections
NIH3T3 fibroblasts in which expression of tTG or tTG-His/myc
is based on pSwitch-pGene dual plasmid expression system
(Invitrogen) were described [26,34]. HUVECs (Invitrogen) were
used between 6
th and 10
th passages. WI-38 human lung fibroblasts
were from ATCC. Mutations of the K598, K600, R601 and K602
residues to alanines in tTG were introduced by PCR-based site-
directed mutagenesis. wt-NSF-myc, E239Q-NSF-myc, TeTx-LC,
SNAP23-myc, dc9-SNAP23-myc, GFP-wt-Rab11A/B, and GFP-
S25N-Rab11A/B constructs were expressed in NIH3T3-tTG
fibroblasts using transfection with Neofectin (MidAtlantic Biolabs).
Transient expression of pre-designed and verified shRNAs for
mouse Rab4A/B, Rab11A/B, Arf6, Rab5A, Rab22A, Tsg101, and
Vps24 in pGFP-V-PS vector in these cells was achieved by their
transfection with Turbofectin 8.0 (all from Origene Technologies).
Inhibitors
The following inhibitors were used: brefeldin, 0.5 mg/ml;
tunicamycin, 0.2 mg/ml; monensin, 2 mM; bafilomycin, 50 nM;
cytochalasin D, 2 mg/ml; nocodazole, 0.5 mg/ml; sodium chlorate,
75 mM; and glyburide, 50 mM. To alter intracellular [Ca
2+],
BAPTA (5 mM) and Ca
2+ ionophore (10 mM) were used. NEM
(0.6 mM) was used to block ATPaseactivity of NSF. Most inhibitors
were applied 30 min before tTG induction or start of metabolic
labeling. Sodium chlorate was added 12 h before tTG induction.
Neomycin, the drug that slowly penetrates plasma membrane and
sequesters phosphoinositides was used for 18 h at 10 mM.
Cell Surface Biotinylation, Biosynthetic Labeling, and
Detection of Surface tTG and b1 Integrin
To define the surface levels of tTG and b1 integrin, cells were
labeled for 15 min at 4uC with 0.5 mg/ml cell impermeant Sulfo-
NHS-LC-biotin [26,34]. Biotinylated proteins were isolated on
Neutravidin-Agarose. Metabolic labeling with
35S-Translabel and
quantitative immunoprecipitation of tTG and b1 integrins in the
presence of detergents was reported [20,53]. To isolate de novo
synthesized surface tTG and b1 integrins, cells were labeled with
200 mCi/ml
35S-Translabel for 15 min and then chased with
medium containing no radioactivity. At the end of labeling/chase,
cells were surface-biotinylated and the fraction of surface proteins
was obtained as above.
Immunofluorescence Microscopy
WI-38 and NIH3T3-tTG or NIH3T3-tTG-His/myc fibroblasts
[34,39,52] on glass coverslips were fixed with 3% formaldehyde
and permeabilized with 0.1% Triton X-100, fixed/permeabilized
with ice-cold methanol, or permeabilized at 4uC with 0.1%
digitonin in QP buffer containing 4% PEG 40,000, 20 mM PIPES
pH 6.9, 50 mM KCl, 1 mM EDTA, and then fixed with 3%
formaldehyde. Cells were either labeled for tTG with mAbs
CUB7402/TG100 or for exogenous His/myc tagged tTG with
anti-6xHis antibody, and secondary Alexa Fluor 488-labeled IgGs,
or double-labeled for tTG and polyclonal antibodies Rab11,
Rab7, or LAMP1, followed by secondary IgGs conjugated with
Alexa Fluor 488 and Alexa Fluor 594. To relate the intracellular
tTG distribution to membrane compartments, the intracellular
membranes were labeled for 10 min with 10 mg/ml styryl dye
FM4-64FX 30 min before cell fixation and labeling with anti-tTG
antibody. Cells were viewed and photographed with 100x
objective using a Nikon Eclipse E800 microscope (Nikon) and
SPOT RT digital camera. Images were acquired and digitally
merged with Advance Spot software (Diagnostic Instruments).
Alternatively, stained cells were examined with 100x objective
using Zeiss/Bio-Rad 2000 confocal microscope. Images were
acquired and digitally merged with Volocity software (Improvi-
sion).
Immunoelectron Microscopy
For immunoEM analysis, cells were fixed in 4% paraformalde-
hyde, 0.1 M PIPES buffer (pH 7.35), scraped off the tissue culture
vessel, washed, pelleted and enrobed in 2.5% low melting
temperature agarose. Agarose blocks containing cells were
trimmed into ,1m m
3 size, washed and dehydrated by gradually
lowering temperature from 4uCt o220uC in increasing
concentration of ethanol, the infiltrated and embedded in unicryl
at 220uC during 24–48 h. Ultrathin sections were cut on Leica
UC6 microtome (Leica Microsystems) and collected onto formvar
coated nickel grids. Grids were inverted section-side facing down
onto a drop of blocking solution containing 1% BSA, 1% fish
gelatin, 0.01 M glycine in PBS, pH 7.4 for 10 min and transferred
on a droplet of primary antibody diluted in blocking solution for
30 min at room temperature. Then, the grids were washed and
labeled with 6 mm gold and 10 nm-gold conjugated secondary
antibody the same way followed by washing. Finally, grids were
fixed with 2% glutaraldehyde in PBS for 5 min, rinsed with water,
air dried and examined using FEI Technai T12 transmission
electron microscope at 80 kV. Images were acquired with AMT-
XR611 digital camera (Advanced Microscopy Techniques) by
using AMTV600 software.
Inactivation of Recycling Endosomes and Lysosomes
The ablation of recycling endosomes was performed as in [43].
NIH3T3-tTG fibroblasts were incubated with 0.02 mg/ml Tfn-
HRP (Jackson Immunoresearch Laboratories, #015-030-050) in
media for 30, washed once in serum-free DMEM, and incubated
another 15 min and washed twice in ice-cold PBS. Surface-bound
Non-Classical Secretion of Transglutaminase
PLoS ONE | www.plosone.org 11 April 2011 | Volume 6 | Issue 4 | e19414Tfn-HRP was removed by two 5-min washes in 0.15 M NaCl and
20 mM citric acid, pH 5.0. Then, cells were washed with ice-cold
PBS, pH 7.4, and resuspended in PBS containing 0.1 mg/ml
DAB (Sigma). H2O2 was added to a final concentration 0.03% to
the inactivation sample; PBS was added to the control set. Cells
were incubated on ice for 45 min in the dark and the reaction was
stopped by washing cells twice in PBS/BSA 1%. To ablate
lysosomes, a similar procedure was performed with 0.5 mg/ml
free HRP, which accumulates at lysosomal compartments. At the
end of endosomal/lysiosomal ablation, tTG synthesis in the cells
was induced with mifepristone and tTG surface levels were
determined as reported [26,34].
Subcellular Fractionation, Immunoisolation of Organelles
and Proteinase Protection Assays
Subcellular fractionation in the absence of detergents was
performed as described by Andrei et al. [10]. The fraction of light
and medium membranes, lacking nuclei and mitochondria and
containing endosomes, lysosomes, ER, Golgi, and plasma mem-
brane vesicles was further used for immuno-isolaion of organelles.
Primary antibodies directed against the markers of these organelles
were bound to Dynabeads
TM M-280 pre-coated with sheep anti-
rabbit or anti-mouse IgGs (Dynal) according to the manufacturer’s
instructions. The crude fraction of light and medium membranes
(P2 fraction in Andrei et al. [10]) was incubated with primary
antibody-coated magnetic beads for 5 h with continuous slow
rotation at 4uC. Bound immunocomplexes were captured using a
magnetic device, washed four times in 20 mM Tris-HCl (pH 7.4)
and 150 mM NaCl, and analyzed for tTG content by immuno-
blotting together with an aliquot of the input. To isolate plasma
membrane vesicles, NIH3T3-tTG fibroblasts were incubated with
100 mg/ml biotin-labeled Concanavalin A (Sigma) to bind it to the
outside leaflet of the plasma membrane. Then, streptavidin-coated
Dynabeads
TM (Dynal) were used for affinity isolation of plasma
membrane vesicles (59). Proteinase protection experiments with
immunoisolated recycling endosomes were performed by treatment
of vesicles with 0.1 mg/ml proteinase K with or without 0.1%
Triton X-100, sonication for 3610 sec with pistol-type sonicator, or
with 1 M KCl, for 30 min at 4uC.
Binding of tTG to Recycling Endosomes and Membrane
Translocation Experiments
The binding of 0-80 nM [
125I]tTG (sp. act. 1.2610
6 cpm/mg)
to recycling endosomal vesicles was studied at 4uC in the buffer
containing 10 mM TrisCl, pH 6.8, 140 mM NaCl, 5 mM EDTA,
1 mM EGTA. Preincubation with 100x excess of unlabeled tTG
was used to determine and subtract non-specific binding. After
30 min incubation, vesicles were extensively washed by centrifu-
gation, and bound radioactivity was quantified in a gamma
counter. In other experiments, binding of 50 nM unlabeled tTG
to the vesicles was studied after preincubation with 100 mM
purified phosphoinositides. The tTG bound to vesicles was
detected and quantified by SDS-PAGE and immunoblotting and
normalized to the levels of tubulin and Rab11A/Rab11B in these
vesicles.
To study the inward translocation of vesicle-bound tTG, the
recycling endosomes and the cytosol were isolated from the
NIH3T3 cells lacking tTG. The vesicles were incubated for 1 h at
4uC with exogenous tTG, washed, warmed to 37uC for 1 h in the
presence or absence of 5 mM Mg
2+/2 mM ATP and cytosol, and
then treated with proteinase K with or without Triton X-100 [10].
The state of vesicle-bound tTG was defined by SDS-PAGE and
immunoblotting.
Isolation of the Fractions of Internalized and Recycled
Proteins
The fraction of biotinylated internalized proteins in NIH3T3-
tTG fibroblasts was obtained as in [44] by labeling cells with SH-
cleavable sulfo-NHS-SS-biotin 3 h after induction of tTG
synthesis, internalization of biotinylated surface proteins for
15 min at 37uC, and stripping the remaining surface biotin with
MESNA. The fraction of biotinylated recycled proteins was
isolated similarly upon subsequent recycling of internalized
proteins to the cell surface for 45 min at 37uC. The fraction of
biotinylated internalized proteins retained intracellularly after the
recycling was obtained following second MESNA stripping. After
cell lysis, biotinylated and unlabeled associated proteins in these
fractions were isolated on neutravidin-Agarose.
Antibody Uptake Experiments
The binding of Fab fragments of mAb 4G3 against tTG and
mAb 9EG7 against b1 integrins to the cell surfaces and uptake
experiments were performed as reported earlier [34].
In vitro Binding Experiments with tTG and
Phosphoinositides
To determine the interactions of tTG with phospholpid arrays
in vitro, membrane lipid and PIP strips were blocked for 1 h with
1% obalbumin in 50 mM TrisCl pH 7.5; 150 mM NaCl, 0.1%
Tween 20. Purified tTG (0.5 mg/ml) was incubated for 1 h at
25uC with the membranes in the same buffer containing either
1 mM EDTA or 5 mM CaCl2. The bound protein was detected
by immunoblotting for tTG, followed by secondary peroxidase-
labeled IgGs and ECL development.
To define the binding of tTG to synthetic liposomes containing
5% (w/w) individual phosphoinositides (PolyPIPosomes
TM, Ech-
elon Biosciences), 25 ml liposome preparations were incubated on
a rotator with 0-800 nM purified recombinant [
125I]tTG in
10 mM TrisCl pH 6.8, 140 mM NaCl, 5 mM EDTA, 1 mM
EGTA for 30 min at 4uC. Preincubation with 100x excess of
unlabeled tTG was used to determine and subtract non-specific
binding. At the end of incubation, liposomes were washed 5 times
with the same buffer by centrifugation, and the amounts of bound
tTG were quantified in a gamma counter.
Flow Cytometry
Live non-permeabilized NIH3T3-tTG trasfectants expressing
GFP fusion constructs with shRNAs for Rab4A/4B, Rab11A/
11B, Arf6, Rab5A and Rab22A; as well as with wt-Rab11A,
S25N-Rab11A, wt-Rab11B, and S25N-Rab11B, were stained for
cell surface tTG at 4uC with a mixture of mAbs TG100, CUB7402
and 4G3 and phycoerythrin- (PE)-labeled secondary antibody as
described [26,34,52]. At the end of the procedure, the cells were
washed and fixed with 0.5% formaldehyde. Two color flow
cytometry of cells was performed using FACSCanto
TM instrument
and FACSDiva software (BD Biosciences). The results were
analyzed for gated intact cells using FCS3 Express software
(DeNovo).
Densitometry and Statistical Analysis
Peroxidase-conjugated secondary antibodies and enhanced
chemiluminescence (ECL) was used for signal detection. The
signals for protein bands were quantified with NIH Image 1.63f
software. Statistical significances were determined using unpaired,
two-tailed Student’s t tests assuming equal variances and an alpha
level of 0.05. Differences were considered significant if the p value
was ,0.05.
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Figure S1 Dynamic equilibrium between externaliza-
tion and endocytic removal of tTG from the cell surface.
NIH3T3-tTG fibroblasts were left untreated or were treated for 30
min with 200 mM dynamin inhibitor dynasore before induction of
tTG synthesis with mifepristone. The surface levels of tTG and b1
integrin were defined after cell surface biotinylation and isolation
of surface proteins (see Materials and Methods) by immunoblot-
ting of cell surface protein fraction. The relative amounts of tTG
and b1 integrin on the surface of dynasore-treated NIH3T3-tTG
fibroblasts were compared to those in untreated cells. Shown is
representative of three independent experiments. Bars depict
means 6 SEM, *p,0.05. The total tTG and actin levels were
defined by direct immunoblotting. Note that dynasore increases
surface levels of tTG and b1 integrin. However, tTG internali-
zation from the cell surface affects its levels during the late, but not
the early phase of secretion. Related to Figure 1.
(TIF)
Figure S2 Heat shock and Cu
2+ chelator do not affect
tTG externalization. NIH3T3-tTG fibroblasts were treated for
18 h with 0-0.2 mM Cu
2+ chelator ammonium tetrathiomolybdate
(TTM) before inducton of tTG synthesis for 4 h. During the last
hour of tTG synthesis, cells were left at 37uC or switched to 42uC.
The surface tTG levels were defined after cell surface biotinylation
and isolation of surface proteins (see Materials and Methods) by
immunoblotting of cell surface protein fraction. The relative tTG
levels on the surface of NIH3T3-tTG fibroblasts were compared
with those in untreated cells at 37uC. Shown is representative of
three independent experiments. Bars depict mean values 6 SEM.
The total tTG and tubulin levels were defined by direct
immunoblotting. Note that heat shock and alteration of cellular
Cu
2+ levels, which affect the non-classical secretion of FGF1 [36],
do not alter tTG externalization. Related to Figure 2.
(TIF)
Figure S3 Intracellular localization of tTG in fibro-
blasts. (A,B) NIH3T3-tTG-His/Myc fibroblasts [39] were
induced to synthesize His/myc-tagged tTG for 24 h (A) or
indicated time (B). Cells were either fixed and permeabilized with
formaldehyde and Triton X-100 (A), or extracted with digitonin
before fixation (B), and then stained for tTG with antibody to
6xHis tag. Note tTG localization of in focal adhesions (arrow-
heads, (A)) and in perinuclear vesicles (asterisks, (B)). Immunoflu-
orescence was analyzed by conventional microscopy. (C,D)
NIH3T3-tTG fibroblasts were induced to synthesize tTG for
3 h. (C) Digitonin-extracted cells were double-stained for tTG and
the late endosomal marker Rab7, or lysosomal marker Lamp1.
Inserts show magnified perinuclear areas. Note a general lack of
tTG co-localization with late endosomes and lysosomes. Immu-
nofluorescence was analyzed by laser confocal microscopy. Bars -
10 mm. (D) Immunoelectron microscopic localization of tTG in
NIH3T3-tTG fibroblasts. Double labeling of thin sections was
performed for tTG (6 nm gold, arrowheads) and Rab11 (10 nm
gold, arrows). NM - nuclear membrane; MVE - multivesicular
endosome; ILV - intraluminal vesicle, also is shown as insert at
higher magnification. Note the localization of tTG inside multi-
vescular endosome on intraluminal vesicle. Related to Figure 3.
(TIF)
Figure S4 ESCRT function is not involved in tTG
secretion. Depletion of Tsg101 and Vps24, the components of
ESCRT-I and ESCRT-III complexes, respectively, was achieved
by simultaneous transfection of shRNAs for these proteins into
NIH3T3-tTG fibroblasts. tTG synthesis in these and control
transfectants expressing scrambled shRNAs was induced for 4 h
prior to cell surface biotinylation and isolation of surface proteins.
Cell surface tTG levels and total levels of TSG101, Vps24, tTG,
and tubulin were defined by immunoblotting. The relative surface
level of tTG in the TSG101-, Vps24-depleted cells was compared
to that in control transfectants expressing scrambled shRNAs.
Shown is a representative of three independent experiments. Bars
show means 6 SEM. Related to Figure 3.
(TIF)
Figure S5 The interaction of tTG with phospholipids in
vitro and in cells. (A,B) Interaction of tTG with phospholipids
in vitro. Specificity and Ca
2+ dependence of the interaction of tTG
with membrane lipids (A) and phospholipids (B) in vitro was studied
with membrane arrays (Echelon Biosciences). Bound tTG was
detected by immunoblotting. (C,D) Interaction of tTG with
phospholipids in cells. (C) tTG was immunoprecipitated from
extracts of WI-38 fibroblasts. The resulting immune complexes
and recombinant tTG purified from E. coli (Zedira) were analyzed
by SDS-PAGE and immunoblotting with antibodies against PI(3)P
and PI(4)P. Only the endogenous protein from fibroblasts, but not
the recombinant tTG binds phosphoinositides. (D) Mutation of the
presumed phospholipid-binding site interferes with the tTG-
phosphoinositide association in fibroblasts. Wild type (wt) and
K598A,K600A,R601A,K602A (m-plbs) mutant were expressed in
NIH3T3 fibroblasts, then immunoprecipitated from cell extracts
and tested for bound phospholipids by immunoblotting with
antibodies against PI(3)P or PI(4)P. Shown in (A-D) are
representative of three independent experiments. Related to
Figure 6.
(TIF)
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